Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Bruker Announces the Appointment of Institute Director, Biopharma Entrepreneur, and Immunology Leader Dr. Eicke Latz to Its Board of Directors

its leadership in post-genomic life-science tools for disease biology research, molecular diagnostics, and biopharma drug discovery and development, Eicke’s scientific-medical vision, biopharma insights, strategic and leadership experience will be...

ProBio Signs Exclusive Global Licensing Agreement with AbTis for Next-Generation ADC Development

ProBio, a global contract research, development, and manufacturing organization announced that it has entered into an exclusive global licensing agreement with AbTis Co., Ltd., a South Korean biotechnology company and subsidiary of Dong-A ST,...

Avanzanite Announces an Exclusive Agreement to License and Market Zemcelpro® in Europe

Avanzanite Bioscience B.V. a European pharmaceutical company focused on rare diseases, announced the conclusion of an exclusive licensing agreement with Montreal-based company Cordex Biologics, an ExCellThera Group company (“ExCellThera”), a...

Pythia Labs Launched AI-Designed Antibodies for Hard-to-Drug Targets

targets. Its scientists and engineers combine expertise in generative modeling, computational biology and drug discovery to open new possibilities for creating better medicines.

Pythia Labs Launched AI-Designed Antibodies for Hard-to-Drug Targets

targets. Its scientists and engineers combine expertise in generative modeling, computational biology and drug discovery to open new possibilities for creating better medicines.

MEPSGEN Launched NanoCalibur® Mini for Nanoparticle Formulation in Small Volumes

launch of NanoCalibur® Mini, an automated system for small-volume nanoparticle formulation designed for early-stage drug discovery and development. Nanoparticles are delivery vehicles that carry therapeutic payloads to target sites in the body, and...

NextGen Pharma 2026

researchers, industry leaders, regulators, and healthcare professionals to discuss transformative advancements in drug discovery, development, delivery systems, personalized medicine, and digital health. At NextGen Pharma, we aim to foster...

2nd International Conference on Drug Discovery 2026

The 2nd International Conference on Drug Discovery 2026, organized by Scisynopsis Conferences, aims to bring together researchers, scientists, industry leaders, and academicians from around the world to explore groundbreaking innovations in drug...

Carterra Advances Drug Discovery Through New Lab-In-The-Loop Scientific Collaboration

a leading provider of high-throughput surface plasmon resonance (HT-SPR™) platforms for antibody and small molecule drug discovery, announced a research collaboration with AstraZeneca to develop hardware and software aimed at advancing lab-in-the...

Tsingke Enables High-Throughput Validation of AI-Designed Proteins and Antibodies

and reliability. Backed by advanced automation and a global scientific team, Tsingke accelerates innovation in drug discovery, functional genomics, and genetic engineering—empowering researchers worldwide with cutting-edge biomanufacturing...

Tsingke Enables High-Throughput Validation of AI-Designed Proteins and Antibodies

and reliability. Backed by advanced automation and a global scientific team, Tsingke accelerates innovation in drug discovery, functional genomics, and genetic engineering—empowering researchers worldwide with cutting-edge biomanufacturing...

Chemify Becomes the First Chemistry Hyperscaler with £22 Million in Grants from Scottish Enterprise and the UK Government

100. “Just one year ago, our first Chemifarm in Glasgow proved that Chemputation works by grounding AI-enabled drug discovery in physical synthesis and improving the design and makeability of new molecules and materials,” said Lee Cronin, CEO and...

Bruker Announces Majority Stake in MIMETAS to Accelerate Drug Discovery and Development Using Human Physiology-Relevant Models

investment in MIMETAS B.V., a developer of organ-on-a-chip platforms and advanced human tissue and disease models for drug discovery and development. The investment expands Bruker’s post-genomic solutions for disease biology research, as well as...

Takeda's ORZEYFUL™ Receives U.S. FDA Approval for Narcolepsy Type 1

Takeda announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent...

Children's Hospital of Philadelphia Initiative Substantially Increases Naloxone Co-Prescribing When Prescribing Outpatient Opioids

A multidisciplinary team at Children's Hospital of Philadelphia (CHOP) substantially increased naloxone co-prescribing for patients prescribed outpatient opioid prescriptions through an enterprise-wide quality improvement initiative designed to...

BioMarin's Supplemental New Drug Application for Full Approval of VOXZOGO® (vosoritide) for Children With Achondroplasia Accepted by the U.S. Food and Drug Administration

with nine commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines...

Strong Performance Across More Than 200 Customer Audits Highlighted by Piramal Pharma Solutions

facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process and pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and...

Cryo-EM Collaboration Between Gandeeva and Zymeworks Speeds Antibody Drug Discovery

validating antibodies derived by immunization and by computational design." About Gandeeva Gandeeva Therapeutics is a drug discovery company leveraging cryo-EM to advance the development of precision medicines. Headquartered in Vancouver, Canada,...

Digi-Tech Pharma & AI Conference 2026

The enhancements in data management and data integration are providing improvements to both the speed and quality of drug discovery and many clinical trial processes. To be in the forefront, a necessity for partnership and collaboration with...

Ascletis announces completion of enrollment in its U.S. Phase II study evaluating ASC30, an oral small-molecule GLP-1R agonist, for diabetes treatment

therapeutics to treat metabolic diseases. Utilizing its proprietary Artificial Intelligence-assisted Structure-Based Drug Discovery (AISBDD) and Ultra-Long-Acting Platform (ULAP) technologies as well as Peptide Oral Transport ENhancement Technology...

Results 1 - 20 of 120